Gajusta, Jiecel J.
HRN: 21-32-08 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2022
AMPICILLIN 1GM (VIAL)
05/07/2022
05/14/2022
IVTT
2g
Q6H
PROM X 24H
Waiting Final Action
05/07/2022
AMPICILLIN 1GM (VIAL)
05/07/2022
05/14/2022
IVTT
2g
Q6H
PROM X 24H
Waiting Final Action
05/07/2022
CEFUROXIME 500MG (TAB)
05/07/2022
05/14/2022
PO
500mg
Q12H
UTI
Waiting Final Action